Search

Elizabeth A Nardin

from Montgomery Village, MD
Age ~40
Get Report
Also known as:
Liz A Nardin
Phone and address:
10111 Watkins Mill Pl, Gaithersburg, MD 20886
Related to:
Jonas KarczJames J Karcz, 48Gail T Benedetto, 73Michael A Benedetto, 47Bertrand S NardinWayne A Rochester, 66Vincent G Benedetto, 47Nicole L Oblenis, 49Paul J Nardin, 41
Connected to:
Alejandro L Nardin, 54Amy J Nardin, 55David M Nardin, 64Jane B Nardin, 81Laura A Nardin, 49Richard C Nardin, 73William Nardin, 66Myles A Nardinger, 41Andrea Nardini, 38Cara L Nardini, 32

Elizabeth Nardin Phones & Addresses

  • 10111 Watkins Mill Pl, Montgomry Vlg, MD 20886
  • Montgomery Village, MD
  • 67 Wilson Ave, Valhalla, NY 10595 (914) 428-2585
  • Oneonta, NY

Skills

Infectious Diseases • Immunology

Resumes

Resumes

Elizabeth Nardin Photo 1

Elizabeth Nardin

View page
Skills:
Infectious Diseases
Immunology

Publications

Us Patents

Universal T-Cell Epitopes For Anti-Malarial Vaccines

View page
US Patent:
20050249750, Nov 10, 2005
Filed:
Nov 17, 2003
Appl. No.:
10/716189
Inventors:
Elizabeth Nardin - Leonia NJ, US
Alberto Moreno - Santafe De Bogota, CO
Assignee:
New York University - New York NY
International Classification:
A61K039/002
A61K039/015
US Classification:
424191100
Abstract:
The present invention provides methods and compositions for eliciting protective immunity against malaria. In particular, the invention relates to universal T-cell epitopes that elicit T-cell responses; in individuals of differing genetic backgrounds. Immunogenic compositions and vaccines comprising malaria-specific universal T-cell epitopes are disclosed.

Methods And Compositions For Malaria Prophylaxis

View page
US Patent:
20090092619, Apr 9, 2009
Filed:
Oct 3, 2007
Appl. No.:
11/866738
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
International Classification:
A61K 39/395
C07K 16/00
US Classification:
4241411, 5303871, 5303881, 4241301
Abstract:
A composition for preventing malaria infection including a steric inhibitor of circumsporozoite protein cleavage. A pharmaceutical composition for preventing malaria infection including a steric inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by sterically inhibiting circumsporozoite protein processing or by directly inhibiting a protease of a sporozoite from binding to its target. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing through steric or direct inhibition.

Methods And Compositions For Malaria Prophylaxis

View page
US Patent:
20110223179, Sep 15, 2011
Filed:
Dec 10, 2010
Appl. No.:
12/965622
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
Assignee:
New York University - New York NY
International Classification:
A61K 39/395
A61P 33/06
US Classification:
4241721
Abstract:
A composition for preventing malaria infection including a steric inhibitor of circumsporozoite protein cleavage. A pharmaceutical composition for preventing malaria infection including a steric inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by sterically inhibiting circumsporozoite protein processing or by directly inhibiting a protease of a sporozoite from binding to its target. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing through steric or direct inhibition.

Methods And Compositions For Malaria Prophylaxis

View page
US Patent:
20130022612, Jan 24, 2013
Filed:
Sep 24, 2012
Appl. No.:
13/625620
Inventors:
NEW YORK UNIVERSITY - New York NY, US
Alida COPPI - Flushing NY, US
Elizabeth NARDIN - Leonia NJ, US
Assignee:
NEW YORK UNIVERSITY - New York NY
International Classification:
A61K 39/395
A61P 33/06
C07K 16/20
US Classification:
4241511, 5303891, 4241721, 5303886
Abstract:
A composition for preventing malaria infection including a steric inhibitor of circumsporozoite protein cleavage. A pharmaceutical composition for preventing malaria infection including a steric inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by sterically inhibiting circumsporozoite protein processing or by directly inhibiting a protease of a sporozoite from binding to its target. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing through steric or direct inhibition.

Universal T-Cell Epitopes For Anti-Malarial Vaccines

View page
US Patent:
6669945, Dec 30, 2003
Filed:
Jan 21, 1998
Appl. No.:
09/060450
Inventors:
Elizabeth Nardin - Leonia NJ
Alberto Morena - Santafé de Bogotá CO
Assignee:
New York University - New York NY
International Classification:
A61K 3804
US Classification:
4242721, 4241911, 4241931, 530300, 530323, 530326, 530806, 530822
Abstract:
The present invention provides methods and compositions for eliciting protective immunity against malaria. In particular, the invention relates to universal T-cell epitopes that elicit T-cell responses in individuals of differing genetic backgrounds. Immunogenic compositions and vaccines including malaria-specific universal T-cell epitopes are disclosed.
Control profile
Elizabeth A Nardin from Montgomery Village, MD, age ~40 Get Report